Mitchell A. Lazar, MD, PhD
Willard and Rhoda Ware Professor in Diabetes and Metabolic Diseases
Perelman School of Medicine University of Pennsylvania
Mitchell A. Lazar, MD, PhD is the Willard and Rhoda Ware Professor of Diabetes & Metabolic Diseases at the University of Pennsylvania Perelman School of Medicine. He was an undergraduate at MIT, received his MD and PhD from Stanford University, and trained in internal medicine and endocrinology at Brigham and Women’s Hospital and Massachusetts General Hospital before joining the University of Pennsylvania faculty in 1989. He served as Chief of the Penn Division of Endocrinology, Diabetes, and Metabolism from 1996-2020, and is the current and Founding Director of the Institute for Diabetes, Obesity and Metabolism. Dr. Lazar has made fundamental contributions to the fields of endocrinology, nuclear receptors, and the transcriptional regulation of metabolism. His groundbreaking research has uncovered mechanisms by which the environment interacts with the genome to regulate circadian rhythms and metabolism and how these impact the epidemics of obesity and diabetes. He has been elected to the American Society for Clinical Investigation and its Council, and to the Association of American Physicians and its council, which he served as president in 2020-2021. Dr. Lazar is also an elected member of the National Academy of Medicine, the American Academy of Arts and Sciences, and the National Academy of Science. He has received numerous awards from international societies and universities, including the Transatlantic Medal from the UK Endocrine Society, the Luft Medal from the Karolinska Institute, and the Harrison Medal from the Endocrine Society of Australia. Dr. Lazar is also the recipient of the 2023 Fred Conrad Koch Lifetime Achievement Award of the Endocrine Society.